Form 4: Immunovant CFO Sells Shares to Cover Tax Obligations

Eva Renee Barnett, CFO of Immunovant, Inc., sold 3,689 shares of common stock on April 9, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• On April 9, 2024, Eva Renee Barnett, the Chief Financial Officer of Immunovant, Inc., sold 3,689 shares of Immunovant's common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of 8,938 restricted stock units (RSUs) on April 4, 2024.
• The shares were sold at a weighted average price of $31.18, with individual transactions ranging from $30.73 to $31.45 per share.
• Following the transaction, Barnett directly owns 371,709 shares of Immunovant common stock.
• The sale was mandated by Immunovant's policy requiring 'sell to cover' transactions for tax obligations, and does not represent a discretionary transaction by Barnett.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transaction is a routine sale to cover tax obligations and doesn't necessarily reflect a change in the executive's outlook on the company.

Management Comments

• The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary transaction by the Reporting Person.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives. This transaction is not necessarily indicative of a change in sentiment regarding the company's prospects.

Comparison to Industry Standards

• Similar 'sell to cover' transactions are routinely observed across the biotechnology and pharmaceutical industries, including companies like Amgen, Regeneron, and Gilead Sciences.
• Executive compensation packages often include RSUs, and the subsequent tax obligations typically lead to similar sales to cover the associated liabilities.
• The percentage of shares sold relative to the total holdings is a key metric to assess the impact of such transactions; in this case, the sale represents a small fraction of Barnett's total holdings.

Stakeholder Impact

• The sale of shares could have a minor, temporary impact on the stock price due to increased selling pressure.
• The transaction ensures compliance with tax regulations, which is beneficial for the company's overall financial health and reputation.

Key Dates